678 related articles for article (PubMed ID: 15039386)
41. Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosis.
Menge T; Lalive PH; von Büdingen HC; Genain CP
J Neuroinflammation; 2011 Nov; 8():161. PubMed ID: 22093619
[TBL] [Abstract][Full Text] [Related]
42. Prevalence of anti-myelin oligodendrocyte glycoprotein antibodies across neuroinflammatory and neurodegenerative diseases.
Trivedi RR; Archambault AS; Pavlak C; Gastaldi M; Cantoni C; Ghezzi L; Cross AH; Miller TM; Wu GF
J Neurol Sci; 2024 Jun; 461():123041. PubMed ID: 38744216
[TBL] [Abstract][Full Text] [Related]
43. High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.
Hecker M; Fitzner B; Wendt M; Lorenz P; Flechtner K; Steinbeck F; Schröder I; Thiesen HJ; Zettl UK
Mol Cell Proteomics; 2016 Apr; 15(4):1360-80. PubMed ID: 26831522
[TBL] [Abstract][Full Text] [Related]
44. Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls.
Van der Aa A; Hellings N; Bernard CC; Raus J; Stinissen P
J Neuroimmunol; 2003 Apr; 137(1-2):164-76. PubMed ID: 12667661
[TBL] [Abstract][Full Text] [Related]
45. Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein.
Lindert RB; Haase CG; Brehm U; Linington C; Wekerle H; Hohlfeld R
Brain; 1999 Nov; 122 ( Pt 11)():2089-100. PubMed ID: 10545394
[TBL] [Abstract][Full Text] [Related]
46. Autoreactivity to myelin antigens: myelin/oligodendrocyte glycoprotein is a prevalent autoantigen.
Diaz-Villoslada P; Shih A; Shao L; Genain CP; Hauser SL
J Neuroimmunol; 1999 Sep; 99(1):36-43. PubMed ID: 10496175
[TBL] [Abstract][Full Text] [Related]
47. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein.
O'Connor KC; McLaughlin KA; De Jager PL; Chitnis T; Bettelli E; Xu C; Robinson WH; Cherry SV; Bar-Or A; Banwell B; Fukaura H; Fukazawa T; Tenembaum S; Wong SJ; Tavakoli NP; Idrissova Z; Viglietta V; Rostasy K; Pohl D; Dale RC; Freedman M; Steinman L; Buckle GJ; Kuchroo VK; Hafler DA; Wucherpfennig KW
Nat Med; 2007 Feb; 13(2):211-7. PubMed ID: 17237795
[TBL] [Abstract][Full Text] [Related]
48. Analysis of interleukin-4 receptor alpha chain variants in multiple sclerosis.
Hackstein H; Bitsch A; Bohnert A; Hofmann H; Weber F; Ohly A; Linington C; Mäurer M; Poser S; Rieckmann P; Bein G
J Neuroimmunol; 2001 Feb; 113(2):240-8. PubMed ID: 11164908
[TBL] [Abstract][Full Text] [Related]
49. Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis.
Vogt MH; Teunissen CE; Iacobaeus E; Heijnen DA; Breij EC; Olsson T; Brundin L; Killestein J; Dijkstra CD
J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1110-5. PubMed ID: 18931010
[TBL] [Abstract][Full Text] [Related]
50. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls.
Hellings N; Barée M; Verhoeven C; D'hooghe MB; Medaer R; Bernard CC; Raus J; Stinissen P
J Neurosci Res; 2001 Feb; 63(3):290-302. PubMed ID: 11170179
[TBL] [Abstract][Full Text] [Related]
51. HLA class II transgenic mice authenticate restriction of myelin oligodendrocyte glycoprotein-specific immune response implicated in multiple sclerosis pathogenesis.
Khare M; Rodriguez M; David CS
Int Immunol; 2003 Apr; 15(4):535-46. PubMed ID: 12663683
[TBL] [Abstract][Full Text] [Related]
52. Autoreactive T and B cells in nervous system diseases.
Sun JB
Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
[TBL] [Abstract][Full Text] [Related]
53. [Epitopes on myelin proteins recognized by autoantibodies present in multiple sclerosis patients].
Jaśkiewicz E
Postepy Hig Med Dosw (Online); 2004; 58():472-82. PubMed ID: 15765008
[TBL] [Abstract][Full Text] [Related]
54. Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis.
Verbeek MM; Notting EA; Faas B; Claessens-Linskens R; Jongen PJ
Acta Neurol Scand; 2010 May; 121(5):309-14. PubMed ID: 19925532
[TBL] [Abstract][Full Text] [Related]
55. Antibody response to myelin oligodendrocyte glycoprotein and myelin basic protein depend on familial background and are partially associated with human leukocyte antigen alleles in multiplex families and sporadic multiple sclerosis.
Lutterotti A; Reindl M; Gassner C; Poustka K; Schanda K; Deisenhammer F; Berger T
J Neuroimmunol; 2002 Oct; 131(1-2):201-7. PubMed ID: 12458053
[TBL] [Abstract][Full Text] [Related]
56. Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.
Jarius S; Metz I; König FB; Ruprecht K; Reindl M; Paul F; Brück W; Wildemann B
Mult Scler; 2016 Oct; 22(12):1541-1549. PubMed ID: 26869529
[TBL] [Abstract][Full Text] [Related]
57. Anti-myelin oligodendrocyte glycoprotein B-cell responses in multiple sclerosis.
Kennel De March A; De Bouwerie M; Kolopp-Sarda MN; Faure GC; Béné MC; Bernard CC
J Neuroimmunol; 2003 Feb; 135(1-2):117-25. PubMed ID: 12576231
[TBL] [Abstract][Full Text] [Related]
58. Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event.
Rauer S; Euler B; Reindl M; Berger T
J Neurol Neurosurg Psychiatry; 2006 Jun; 77(6):739-42. PubMed ID: 16705196
[TBL] [Abstract][Full Text] [Related]
59. Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis.
Avsar T; Korkmaz D; Tütüncü M; Demirci NO; Saip S; Kamasak M; Siva A; Turanli ET
Mult Scler; 2012 Aug; 18(8):1081-91. PubMed ID: 22252467
[TBL] [Abstract][Full Text] [Related]
60. Immunopathogenic and clinical relevance of antibodies against myelin oligodendrocyte glycoprotein (MOG) in Multiple Sclerosis.
Berger T; Reindl M
J Neural Transm Suppl; 2000; (60):351-60. PubMed ID: 11205153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
